Kevin Fitzpatrick

Jul 07, 2015

Kevin Fitzpatrick has been named CEO of CancerLinQ, a wholly owned non-profit subsidiary of the American Society of Clinical Oncology.

Fitzpatrick will begin his new role on August 3. In the position, he will be responsible for driving the mission, operations, and ensuring the financial sustainability of CancerLinQ, an SAP HANA-based platform for processing and analyzing data from electronic health records.

Fitzpatrick is currently the executive vice president and chief innovation officer of the American College of Cardiology. Prior to that, he was vice president of business development for Lippincott Williams & Wilkins, a publisher of professional health information resources, managing director of the Duke/Hewlett Packard Center for Outcomes Research, and director of the Trauma Research Laboratory at Duke University Medical Center.

Kevin Fitzpatrick

WHO Approves Abbott Molecular Mpox Assay

Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith

Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests

With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research

Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test